Normobaric Hyperoxia for Spinal Cord Injury

(SpiCoH Trial)

This trial tests a new treatment called normobaric hyperoxia, which involves breathing pure oxygen at normal atmospheric pressure, to help individuals with spinal cord injuries breathe better while on a ventilator. The researchers aim to determine if this treatment can improve recovery in patients with traumatic injuries to the neck or upper back. Suitable candidates have a spinal cord injury requiring a ventilator and can follow commands. As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group of participants.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.

Research has shown that breathing pure oxygen, known as normobaric hyperoxia, is safe for individuals with spinal cord injuries. Studies on similar treatments, such as hyperbaric oxygen therapy, have also demonstrated safety. These treatments often boost oxygen levels in the body, aiding healing. Previous findings indicate that normobaric hyperoxia is generally well-tolerated, with few serious side effects reported. This suggests that people typically experience no major issues when undergoing this treatment. Although some risks remain, evidence suggests this approach is relatively safe for spinal cord injury patients.¹²³⁴⁵

Normobaric hyperoxia is unique because it introduces a novel way of treating spinal cord injuries by delivering high levels of oxygen at normal atmospheric pressure. Most traditional treatments for spinal cord injuries, like surgery and rehabilitation, focus on reducing damage and promoting recovery over time. However, normobaric hyperoxia aims to enhance the body's healing process by increasing oxygen availability, potentially reducing inflammation and protecting nerve cells from further damage. Researchers are excited about this approach because it could offer a faster and more efficient recovery path for patients, with fewer side effects compared to more invasive treatments.

Research has shown that breathing extra oxygen at normal pressure, known as normobaric hyperoxia, can greatly enhance oxygen and blood flow to the spinal cord shortly after an injury. This process delivers more oxygen to the injured area, which is crucial for healing. Some evidence also suggests it might reduce nerve pain in patients. However, early data indicates it only slightly aids in preventing further nerve damage after a spinal cord injury. While these findings are promising, more research is needed to confirm these benefits. Participants in this trial will receive normobaric hyperoxia to further investigate these potential advantages.¹²³⁶⁷